Association between uncarboxylated osteocalcin, blood glucose, and BMI among Saudi diabetic patients: an evaluation study
CONCLUSIONS: We concluded that, in Saudi type II diabetes mellitus patients, the compromised glucose level is associated with diminished serum uncarboxylated osteocalcin. This study has limitations, such as a small sample size and only measuring the uncarboxylated form of plasma osteocalcin. Future research is needed to understand how anti-diabetic drugs affect undercarboxylated osteocalcin's effect on metabolic control and provide more efficient techniques and resources in diabetes and osteoporosis prevention and care.PMID:38497883 | DOI:10.26355/eurrev_202403_35615
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: T Alamri F Alhumaydhi A Z Wasti Source Type: research
More News: Calcium | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Middle East Health | Minerals | Obesity | Orthopaedics | Osteoporosis | Saudi Arabia Health | Statistics | Study | Sugar | Urology & Nephrology